Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.350
-0.130 (-3.74%)
At close: Sep 11, 2026, 4:00 PM EDT
3.290
-0.060 (-1.79%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $367.74 million as of September 11, 2026. Its market cap has increased by 7.18% in one year.
Market Cap
367.74M
Enterprise Value
108.80M
1-Year Change
7.18%
Ranking
Category
Stock Price
$3.35
ChartMarket Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $367.74M, an increase of 285.88%. That is a compound annual growth rate of 12.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 367.70M | -3.21% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 407.37M |
| Turn Therapeutics | 405.12M |
| Editas Medicine | 403.92M |
| vTv Therapeutics | 401.94M |
| Arcturus Therapeutics Holdings | 401.33M |
| Fennec Pharmaceuticals | 397.31M |
| Larimar Therapeutics | 395.61M |
| Evommune | 395.22M |